Rubicon Research Ltd
NSE: RUBICON BSE: 544578
₹967.90
(1.01%)
Wed, 27 May 2026, 06:43 pm
Market Cap161.36B
PE Ratio0
Dividend0
Health Technology
Biotechnology
24.5KRubicon Research Balance Sheet
| Particulars | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Interest expense on debt | -97.23M | -179.51M | -303.67M | -329.30M |
| Pretax equity in earnings | 0 | 0 | 0 | 0 |
| Equity in earnings | 0 | 0 | 0 | 0 |
| Total assets | 5.60B | 7.50B | 11.09B | 14.51B |
| Total current assets | 3.28B | 5.02B | 7.63B | 10.63B |
| Cash and short term investments | 526.02M | 589.12M | 583.90M | 1.16B |
| Cash & equivalents | 526.02M | 589.12M | 583.90M | 1.16B |
| Short term investments | 0 | 0 | 0 | 0 |
| Total receivables, net | 1.51B | 2.27B | 3.05B | 3.32B |
| Accounts receivable - trade, net | 1.40B | 2.25B | 3.01B | 3.24B |
| Other receivables | 118.37M | 15.27M | 35.79M | 79.32M |
| Total inventory | 906.51M | 1.74B | 3.14B | 5.30B |
| Other current assets, total | 217.73M | 253.53M | 430.07M | 307.37M |
| Total non-current assets | 2.31B | 2.48B | 3.46B | 3.88B |
| Long term investments | 45.62M | 45.61M | 45.62M | 30.86M |
| Note receivable - long term | — | — | — | — |
| Investments in unconsolidated subsidiaries | 0 | 0 | 0 | 0 |
| Other investments | 45.62M | 45.61M | 45.62M | 30.86M |
| Net property/plant/equipment | 1.81B | 2.06B | 2.64B | 3.03B |
| Gross property/plant/equipment | 2.54B | 2.97B | 3.77B | 4.31B |
| Deferred tax assets | — | — | 9.26M | 17.71M |
| Net intangible assets | 341.23M | 205.58M | 600.74M | 577.98M |
| Goodwill, net | 21.64M | 21.70M | 513.30M | 476.11M |
| Other intangibles, net | 319.59M | 183.88M | 87.44M | 101.87M |
| Other long term assets, total | 83.94M | 106.19M | 81.60M | 138.70M |
| Short term debt | 1.10B | 2.22B | 3.10B | 3.37B |
| Current portion of LT debt and capital leases | 182.96M | 266.00M | 456.57M | 464.45M |
| Short term debt excl. current portion of LT debt | 913.56M | 1.96B | 2.64B | 2.90B |
| Accounts payable | 569.68M | 968.72M | 1.77B | 2.39B |
| Income tax payable | 2.79M | 90.41M | 35.51M | 318.06M |
| Long term debt | 653.44M | 972.77M | 1.31B | 810.42M |
| Long term debt excl. lease liabilities | 653.44M | 972.77M | 1.31B | 810.42M |
| Total equity | 3.05B | 2.86B | 3.85B | 5.41B |
| Shareholders' equity | 3.05B | 2.86B | 3.85B | 5.41B |
| Common equity, total | 3.05B | 2.86B | 3.85B | 5.41B |
| Other common equity | 98.55M | 79.75M | 158.45M | 135.95M |
| Total debt | 1.75B | 3.20B | 4.41B | 4.18B |
| Net debt | 1.22B | 2.61B | 3.83B | 3.01B |
| Change in accounts receivable | 14.27M | -736.63M | -666.52M | -213.54M |
| Change in taxes payable | — | — | — | — |
| Change in accounts payable | 236.75M | 401.71M | 686.70M | 631.81M |
| Change in other assets/liabilities | -133.45M | 30.04M | -100.45M | 892.86M |
| Sale of fixed assets & businesses | 0 | 610.00K | 980.00K | 60.76M |
| Purchase/sale of investments, net | -22.85M | 94.47M | -33.01M | -19.93M |
| Sale/maturity of investments | 143.30M | 94.47M | 0 | 0 |
| Purchase of investments | -166.15M | 0 | -33.01M | -19.93M |
| Other investing cash flow items, total | 0 | 0 | 0 | 0 |
| Issuance/retirement of debt, net | 762.24M | 1.44B | 779.43M | -44.86M |
| Issuance/retirement of long term debt | 284.06M | 439.23M | 103.54M | -296.69M |
| Issuance/retirement of short term debt | 478.18M | 1.00B | 675.89M | 251.83M |
| Issuance/retirement of other debt | — | — | — | — |
| Total cash dividends paid | -5.07M | -2.54M | -2.54M | -3.04M |
| Other financing cash flow items, total | 0 | 0 | 0 | 0 |